The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
about
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of riskThe 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of riskThe 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of riskFRAX and the assessment of fracture probability in men and women from the UKThe 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of riskThe impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: is the whole greater than the sum of its parts?A mathematical model for the burden of diabetes and its complicationsFenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a changeCardiovascular riskEffectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trialEconomics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic ReviewCoronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implicationsA critical dialogue: communicating with type 2 diabetes patients about cardiovascular riskCost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulinGetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world.Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 Diabetes in Canada.Ultrasonic tissue characterization of carotid plaque improves the prediction of cardiovascular events in diabetic patients: a pilot studySub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies.The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trialToward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its ComplicationsA critical review of mathematical models and data used in diabetology.Ambulatory care quality measures for the 6 aims from administrative data.The effectiveness of adding cognitive behavioural therapy aimed at changing lifestyle to managed diabetes care for patients with type 2 diabetes: design of a randomised controlled trialImproving patient adherence to lifestyle advice (IMPALA): a cluster-randomised controlled trial on the implementation of a nurse-led intervention for cardiovascular risk management in primary care (protocol).Community based yoga classes for type 2 diabetes: an exploratory randomised controlled trial.Indirect estimation of a discrete-state discrete-time model using secondary data analysis of regression data.Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.Cardiovascular Disease Incidence and Risk Factor Patterns among Omanis with Type 2 Diabetes: A Retrospective Cohort StudyCardiovascular risk assessment--from individual risk prediction to estimation of global risk and change in risk in the population.Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular riskSmoking amplifies cardiovascular risk in patients with hypertension and diabetes.Should all diabetic patients be treated with a statin?Estimation of the Long-term Cardiovascular Events Using UKPDS Risk Engine in Metabolic Syndrome Patients.Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society.The @RISK Study: Risk communication for patients with type 2 diabetes: design of a randomised controlled trialThe Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infMultiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes.Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
P2860
Q24645401-88B43AC9-5640-4BBA-A1E8-8411DD81A663Q24651499-051DB09D-0AE9-42A8-820C-7E272510EA45Q24652860-00E999C3-22B2-4131-8F8D-1C856E5C8222Q24654123-1FA1F37A-1F5F-47F2-BBA6-79312014F601Q24658014-E556A49E-79AD-4ACE-9866-4116489D3A19Q24799452-02190AA2-EB8C-4F03-B86A-909D5DE6C6C6Q24802282-AD8E8C14-6F3F-46BD-9B9A-E87CA18F3D0EQ24815913-105E61F9-932A-46AA-AB3F-936B61498D1CQ26767122-A832F012-FE8F-4683-AAE6-7B7335D1DC22Q26825634-910B737C-3E9E-45C4-8DD2-3F5D67EE8672Q27335181-6FCB8F0C-C8E8-42C9-8B38-D4411B6F66FBQ28083249-5D496525-03A1-4FF8-80AA-54E144E07569Q28167649-B6F1433D-4D06-4BAD-88C6-48313D63DEC7Q28219258-92281E38-5A00-4F43-99AD-F08335545885Q28268410-2AAE548F-4929-44FF-AE88-54D5A018E65EQ30248472-0142FCCA-31F9-404A-917A-50F0E5060EC6Q30278856-33AF42C5-5D80-44AC-8978-D9725B5455FDQ30446520-5EBF2C9C-4CEF-4193-BA71-85E26FC475BAQ30454904-B2435004-B18C-4E9A-9D0F-F315257B9ABCQ30485840-90BF245D-D754-4A5B-AE65-634B423331D5Q30578346-F117A6B5-817C-41D5-BB79-A283D93C45E0Q31005299-0AAC0C40-F791-4967-AF0D-8E45446D6C0CQ31047512-A8CA14B2-4BAF-4E2D-8B2F-56068952CA35Q31061111-08CCE435-70CC-496D-8007-371544D312B0Q33284067-DE5128D9-E383-4E18-AAB3-11E49F3B5253Q33314627-88D3151D-8802-4559-B111-90BEECC19948Q33410675-E652598F-5D88-4924-A07D-B84F03056247Q33448660-CE62908C-8020-406D-824C-5B1F59E65765Q33501445-C144F8AC-3370-47CE-8F1D-75325DFA18C0Q33580063-E8F62653-11EE-473D-B86F-5B5106813F72Q33586716-BC58E8AC-4D99-411A-9CAB-F0F0DA129092Q33602120-6495354B-C9C5-425D-9503-2DACB56EF22EQ33610650-28A80B9F-159F-4146-B632-C74FAE1A46ACQ33610801-F945F3F1-394D-4FC2-85C0-C3AAA8F7920EQ33621120-C0AE6C8A-1872-443D-924F-7757470BC349Q33647298-4DF72899-1BE2-4E9B-B47B-B566A761EEBCQ33650323-1FFD46BA-99FD-4D2F-A5C7-01EA681C7AE8Q33696402-30F0280D-1FCE-46CE-9112-08EA947D896EQ33698160-FBB4896B-8FD0-495B-B483-096C527CA6DDQ33737219-60F913A0-5B18-47F5-B51E-00A5555BFB98
P2860
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The UKPDS risk engine: a model ...... n Type II diabetes (UKPDS 56).
@en
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes
@nl
type
label
The UKPDS risk engine: a model ...... n Type II diabetes (UKPDS 56).
@en
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes
@nl
prefLabel
The UKPDS risk engine: a model ...... n Type II diabetes (UKPDS 56).
@en
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes
@nl
P2093
P356
P1433
P1476
The UKPDS risk engine: a model ...... n Type II diabetes (UKPDS 56).
@en
P2093
I M Stratton
R J Stevens
United Kingdom Prospective Diabetes Study (UKPDS) Group
P304
P356
10.1042/CS1010671
P407
P577
2001-12-01T00:00:00Z